Evidence map›Paper›PMID 35159701›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Phytogenic Selenium Nanoparticles Elicited the Physiological, Biochemical, and Antioxidant Defense System Amelioration of Huanglongbing-Infected 'Kinnow' Mandarin Plants.

Muhammad Ikram, Naveed Iqbal Raja, Zia-Ur-Rehman Mashwani, Ahmad Alsayed Omar, Azza H Mohamed, Seema Hassan Satti, Efat Zohra

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
10.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Muhammad IkramDepartment of Botany, PMAS Arid Agriculture University, Rawalpindi 46300, Pakistan.
Naveed Iqbal RajaDepartment of Botany, PMAS Arid Agriculture University, Rawalpindi 46300, Pakistan.
Zia-Ur-Rehman MashwaniDepartment of Botany, PMAS Arid Agriculture University, Rawalpindi 46300, Pakistan.ORCID 0000-0003-4222-7708
Ahmad Alsayed OmarBiochemistry Department, Faculty of Agriculture, Zagazig University, Zagazig 44519, Egypt.ORCID 0000-0003-3198-624X
Azza H MohamedCitrus Research and Education Center, University of Florida, IFAS, Lake Alfred, FL 33850, USA.ORCID 0000-0002-4162-8932
Seema Hassan SattiDepartment of Botany, PMAS Arid Agriculture University, Rawalpindi 46300, Pakistan.
Efat ZohraDepartment of Botany, PMAS Arid Agriculture University, Rawalpindi 46300, Pakistan.
Pir Mehr Ali Shah Arid Agriculture University · PKMansoura University · EGZagazig University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Citrus greening or huanglongbing (HLB) is commonly known as yellow dragon disease and affects citrus production worldwide. Therefore, it has a significant impact on and deleterious effects in the agro-industrial sector. Significant efforts have been made to combat this disease and mitigate its destructive impact on citrus production, but still, there is no effective biocompatible treatment available to control HLB disorder. This study is considered the first biocompatible approach to evaluate the potential of phytogenic selenium nanoparticles (SeNPs) to improve the health of HLB-infected 'Kinnow' mandarin plants. Polymerase chain reactions (PCRs) with specific primers were used to detect HLB disease in 'Kinnow' mandarin plants, and PCR products were sequenced to identify

Indexed as

antioxidant systemCandidatus Liberibacter asiaticuscitrushuanglongbingphyto-nanobiotechnologyselenium nanoparticles

Identifiers

PMID35159701
PMCPMC8839265
OpenAlexW4207081913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.